You Be the Analyst

Risk-Adjusted DCF Biotech Valuation Calculators
Utilizes the Same Valuation Model That Wall Street Analysts Use and Rely On
Calculators Are Specific to Each Company - All Numbers are Fully Disclosed
Dynamic - Easy-to-use - Highly Flexible - High Degree of Specificity
All Calculations are 100% Private and Confidential - Calculator loads directly
onto your browser in JavaScript and cannot be seen by anyone else

Featured RNAi Biotech Valuation Calculators:

About

BioBoyScout was founded by Intellectual Property Attorney, Robert Toczycki, JD, MBA. BioBoyScout’s online calculators are open and transparent with all the numbers, allowing users to make their own assumptions and edits throughout hundreds of variables. The result is the world’s first online biotech valuation calculator that helps eliminate bias and openly challenges the private valuation modeling techniques of major Wall Street analysts. You can follow BioBoyScout’s insights and updates on Twitter. Your feedback, along with any questions or comments is greatly appreciated.

Get advanced notices on BioBoyScout’s research, news, and analysis before it hits the streets by signing up at Friends of BioBoyScout.

If you use and like this site, please consider supporting it to help keep it up and running. Thank you for your support.  Donate via Paypal

5 Star Review - 8/15/19
5/5

“As a CPA I perform valuation services so the DCF calc was accurately performed. I happened to buy a few shares of ARWR and sold a few after the price went up.  I also began to pay attention to the posts to better educate myself. I read a few BBS posts and had an epiphany, the posts were professionally crafted and the research very deep. This was far different from past encounters, so the BBS information coerced me to take, over a period of time, a much larger position. An uncomfortable position based upon investment normal allocation, age, risk and other factors, but I accept same. I would like to thank you for your educational services and your ability to share, you are most generous. And Yes, I know the risk. Life is a risk. LLZIII”

2019 Wisconsin Biohealth Summit – Fireside Chat – RNAi and CRISPR: What Can the Platforms Learn from Each Other and What Opportunities Are There?
Panelists: Bruce Given, COO, Arrowhead Pharmaceuticals, Inc. and Peter Newman, VP for Research, Versiti

Copyright © 2018-2022, BioBoyScout | All Rights Reserved.